Table Of Contents
1. Introduction
1.1 Blood Transfusion Diagnostics Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Blood Transfusion Diagnostics Market Snapshot
2.2 Blood Transfusion Diagnostics Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Blood Transfusion Diagnostics Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Blood Transfusion Diagnostics Market Size By Product
2.3.2 Blood Transfusion Diagnostics Market Size By Application
2.3.3 Blood Transfusion Diagnostics Market Size By End-Use
2.3.4 Blood Transfusion Diagnostics Market Size By Technology Type
2.4 Blood Transfusion Diagnostics Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Blood Transfusion Diagnostics Market Overview
3.1 Blood Transfusion Diagnostics Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Blood Transfusion Diagnostics Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Blood Transfusion Diagnostics Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Blood Transfusion Diagnostics Market Overview
3.7 Blood Transfusion Diagnostics Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Average Cost Per Test by Diagnostic Method (NAT, ELISA, Chemiluminescence)
4.1.3 Price Benchmarking by Key Diagnostic Manufacturers
4.1.4 Regional Pricing Differences and Reimbursement Metrics
4.1.5 Emerging Pricing Models: Subscription-Based Reagent Supply & Volume-Based Procurement
4.2 Regulatory & Compliance Landscape
4.2.1 Overview
4.2.2 Compliance with Blood Safety Directives (FDA, EMA, CDSCO) and AABB Standards
4.2.3 Insurance and Liability Frameworks for Transfusion-Transmitted Infections
4.2.4 Policies Promoting Blood Donation Drives and Infrastructure Modernization
4.2.5 Strategic Guidelines for Compliance and Risk Management in Blood Banks
4.3 Technology & Innovation Metrics
4.3.1 Overview
4.3.2 Adoption Rate of Nucleic Acid Amplification Testing (NAT) vs. Serological Immunoassays
4.3.3 Investment in Automated Cross-Matching and High-Throughput Screening Systems
4.3.4 Patent Filings and Technological Innovations in Pathogen Reduction and Molecular Diagnostics
4.3.5 Emerging Trends: Point-of-Care (POC) Blood Typing, AI-Driven Donor Deferral, and Liquid Biopsy Integration
4.4 Operational & Experience Metrics
4.4.1 Overview
4.4.2 Number of Blood Units Screened and Processed Annually (Global & Regional)
4.4.3 Turnaround Time (TAT) Metrics for Emergency Transfusion Requests
4.4.4 Blood Donor Deferral Rates and Donor Retention Analytics
4.4.5 Safety Records: Incidence Rate of Transfusion-Transmitted Infections (TTIs) Post-Screening
4.5 Investment & Strategic Activity
4.5.1 Overview
4.5.2 Venture Capital and Private Equity Investments in Blood Diagnostics Startups
4.5.3 Key M&A Activity and Strategic Partnerships in the Diagnostics Landscape
4.5.4 Collaborations Between Diagnostic OEMs, Blood Banks, and Government Health Agencies
4.5.5 Emerging Innovation Hubs and R&D Centers for Transfusion Medicine
5. Blood Transfusion Diagnostics Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Reagents & Kits
5.2.1 Key Trends
5.2.2 Blood Transfusion Diagnostics Market Size & Forecast, 2022–2035
5.3 Instruments
5.4 Others
6. Blood Transfusion Diagnostics Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Blood Grouping
6.2.1 Key Trends
6.2.2 Blood Transfusion Diagnostics Market Size & Forecast, 2022–2035
6.3 Disease Screening
7. Blood Transfusion Diagnostics Market Segmental Analysis & Forecast, By End-Use, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Hospitals
7.2.1 Key Trends
7.2.2 Blood Transfusion Diagnostics Market Size & Forecast, 2022–2035
7.3 Blood Banks
7.4 Diagnostics Laboratories
7.5 Others
8. Blood Transfusion Diagnostics Market Segmental Analysis & Forecast, By Technology Type, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Nucleic Acid Amplification Testing (NAT)
8.2.1 Key Trends
8.2.2 Blood Transfusion Diagnostics Market Size & Forecast, 2022–2035
8.3 Immunoassays (ELISA, Chemiluminescence)
8.4 Next-Generation Sequencing (NGS) & Molecular Typing
9. Blood Transfusion Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Blood Transfusion Diagnostics Market Size & Forecast, By Product, 2022–2035
9.2.3 Blood Transfusion Diagnostics Market Size & Forecast, By Application, 2022–2035
9.2.4 Blood Transfusion Diagnostics Market Size & Forecast, By End-Use, 2022–2035
9.2.5 Blood Transfusion Diagnostics Market Size & Forecast, By Technology Type, 2022–2035
9.2.6 Blood Transfusion Diagnostics Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Blood Transfusion Diagnostics Market Size & Forecast, By Product, 2022–2035
9.3.3 Blood Transfusion Diagnostics Market Size & Forecast, By Application, 2022–2035
9.3.4 Blood Transfusion Diagnostics Market Size & Forecast, By End-Use, 2022–2035
9.3.5 Blood Transfusion Diagnostics Market Size & Forecast, By Technology Type, 2022–2035
9.3.6 Blood Transfusion Diagnostics Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Blood Transfusion Diagnostics Market Size & Forecast, By Product, 2022–2035
9.4.3 Blood Transfusion Diagnostics Market Size & Forecast, By Application, 2022–2035
9.4.4 Blood Transfusion Diagnostics Market Size & Forecast, By End-Use, 2022–2035
9.4.5 Blood Transfusion Diagnostics Market Size & Forecast, By Technology Type, 2022–2035
9.4.6 Blood Transfusion Diagnostics Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Blood Transfusion Diagnostics Market Size & Forecast, By Product, 2022–2035
9.5.3 Blood Transfusion Diagnostics Market Size & Forecast, By Application, 2022–2035
9.5.4 Blood Transfusion Diagnostics Market Size & Forecast, By End-Use, 2022–2035
9.5.5 Blood Transfusion Diagnostics Market Size & Forecast, By Technology Type, 2022–2035
9.5.6 Blood Transfusion Diagnostics Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Blood Transfusion Diagnostics Market Size & Forecast, By Product, 2022–2035
9.6.3 Blood Transfusion Diagnostics Market Size & Forecast, By Application, 2022–2035
9.6.4 Blood Transfusion Diagnostics Market Size & Forecast, By End-Use, 2022–2035
9.6.5 Blood Transfusion Diagnostics Market Size & Forecast, By Technology Type, 2022–2035
9.6.6 Blood Transfusion Diagnostics Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2025–2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Blood Transfusion Diagnostics Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Illumina, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Thermo Fisher Scientific Inc.
10.6.3 Abbott Laboratories
10.6.4 Grifols
10.6.5 Siemens Healthineers
10.6.6 Roche Diagnostics
10.6.7 Beckman Coulter, Inc.
10.6.8 Becton Dickinson and Company
10.6.9 Ortho Clinical Diagnostics
10.6.10 Bio-Rad Laboratories, Inc.
10.6.11 Akers Biosciences
10.6.12 MacoPharma
10.6.13 F. Hoffmann-La Roche AG
10.6.14 Sysmex Corporation
10.6.15 Quidel Corporation
10.6.16 Abcam
10.6.17 BioMerieux
10.6.18 Sekisui Diagnostics
10.6.19 Diacor
10.6.20 Wako Pure Chemical Industries, Ltd.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Blood Transfusion Diagnostics Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Blood Transfusion Diagnostics Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Ans: North America dominated the market in 2025 with a 40.46% share, supported by advanced healthcare infrastructure, technological adoption, and stringent regulatory standards for transfusion safety.
Ans: Reagents & Kits dominated the market with 65.23% share, owing to their critical role in accurate blood testing, innovation, and widespread adoption across diagnostics applications.
Ans: Rising incidence of blood disorders, increasing demand for safe transfusions, and the adoption of advanced diagnostic technologies are the key factors driving market growth.
Ans: The Blood Transfusion Diagnostics Market size in 2025 was valued at USD 4.88 billion, reflecting increasing adoption of automated testing, immunoassays, and molecular diagnostics globally.
Ans: The Blood Transfusion Diagnostics Market is expected to grow at a CAGR of 5.91% from 2026 to 2035, driven by rising blood disorder prevalence and transfusion demand.
Get in Touch
Rohan Jadhav
Principal Consultant
